A few anti‐inflammatory strategies for the treatment of HGPS have been poorly explored (Lai & Wong, 2020) though some of the drugs that treat HGPS such as metformin, resveratrol, rapamycin, quercetin or spermidine indirectly inhibit inflammatory pathways such as the NLRP3 inflammasome (Cordero et al, 2018). The gene discussed is NLRP3; the disease is Hutchinson-Gilford progeria syndrome.